Certified by Founder Lodge
Insamo
United States - San Francisco Bay Area
START UP
1 Disclosed Funding Rounds $12,000,000
0 Participating Investments
-
Founded date
2022
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Pioneering the discovery of membrane-permeable and orally-available cyclic-peptides with antibody-like binding affinity.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| February, 22 ,2024 | Seed | $12,000,000 |
Sahsen Ventures, LLC
Civilization Ventures
Axial
BEVC
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
AIRRIVED | $6,100,000 | (Feb 4, 2026)
Derapi | $7,000,000 | (Feb 4, 2026)
Arbor(US) | $6,300,000 | (Feb 4, 2026)
Graici | $7,500,000 | (Feb 4, 2026)
enclaive | $4,849,418 | (Feb 4, 2026)
